-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-mri-utilization_research.pdf
August 01, 2012 - increased
dramatically from 2002 to 2007 for both
women with DCIS (<1% to 12.9%) and with
invasive disease … Specifically, we
included International Classification of
Diseases for Oncology, Third Edition
(ICD-O … Among women with
invasive cancer, rates of MRI use de-
creased with higher grade disease. … The increase
was observed for both women with DCIS
and early invasive disease. … ) received more MRIs
prior to surgery than those with lower risk
disease.
-
effectivehealthcare.ahrq.gov/products/lysosomal-storage-diseases-therapies/technical-brief
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
October 30, 2012 - such as in cancer or H5N1
influenza; or to manage or reduce the burden of
chronic diseases including … diabetes, psoriasis,
Parkinson’s disease, and depression. … only
six items.34 In contrast, other popular measures
focus on symptoms that are affected by many
diseases … Statistical validation of intermediate endpoints for
chronic diseases. … The
use of Systemic Lupus Erythematosus Disease
Activity Index-2000 to define active disease and
minimal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
January 24, 2022 - : 3 (8.6)
Cardiovascular disease: 4 (11.4)
CKD: 1 (2.9)
Chronic lung disease: 3 (8.6) CMIA
ELISA Abbott … )
Pulmonary disease: 2 (12.5)
Heart disease: 2 (12.5) CLIA IgG, IgM ManglumiTM 2019 nCovIgM and the MaglumiTM … controlled cohort 10 HIV Adult COVID-19 patients who were hospitalized in the Department of Infectious Diseases … 2020 - 11/30/2020 COVID-19 patients >18 yrs old who were hospitalized in the Department of Infectious Diseases … patients) The Transplant Institute, Sahlgrenska University Hospital, and the Department of Infectious Diseases
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
December 16, 2011 - and Objectives for the Systematic Review
Overview
Restless legs syndrome (RLS) or Willis-Ekbom disease … If the disease progresses, symptoms may
occur earlier in the day and intensify even further at night … are used to assess disease severity and treatment-
induced changes in disease status. … Yet, the disease is chronic, often requiring life-long treatment. … and definition of clinically significant
change in disease status used in individual studies.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dyspnea_research.pdf
April 01, 2010 - requires valid, reliable, and responsive
measures of the care provided to patients across settings and diseases … review of over 5000 titles in Western literature for quality measures of symptom
management across diseases … care
measure set.17 The dyspnea measure evaluates the proportion of patients with advanced chronic
diseases … VAS were felt by panelists to be appropriate for clinical dyspnea assessment in chronic
progressive diseases … Descriptors of breathlessness in
cardiorespiratory diseases.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_research-protocol.pdf
March 09, 2010 - arthritis (JIA), formerly known as juvenile rheumatoid arthritis, is the
most common rheumatologic disease … with more destructive joint disease … Evaluating changes in JIA disease status can be challenging. … First, these measures evaluate relative and not absolute changes in
disease progression. … Effects of Omega-3 Fatty Acids on Cardiovascular
Disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes.pdf
April 01, 2005 - Imaging test:
Laboratory test:
Clinical exam test:
Demographics:
Concurrent diseases … Survival in renal vascular disease. … Surgery for
renovascular diseases: a single-center
experience in revascularizing renal artery
stenosis … HTN and CKD
• Populations had ≥60%
to ≥80% stenosis
• Populations had
unilateral and bilateral
diseases … that bilateral
versus unilateral
disease did not predict
progressive kidney
disease
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0277_03-10-2008.pdf
January 01, 2008 - HSCTs are used to treat both malignant and non-malignant diseases in children. … HSCT is
associated with high morbidity and mortality in all ages and all diseases. … Factors that impact the
appropriateness and success of any HSCT include the stage and/or severity of the disease … ),
there is a large body of literature regarding HSCT across many diseases. … The diseases covered in the AHRQ review will be defined during the refinement
phase.
-
effectivehealthcare.ahrq.gov/sites/default/files/clinical-pathway-methods-report-appendix-k.pdf
February 01, 2018 - Australasian Society of
Infectious Diseases
20164
Oral antibiotic treatment – nonsevere disease … ; FMT: Fecal
microbiota transplantation; ID: infectious disease; SHEA/IDSA: Infectious Diseases Society … Debast SB, Bauer MP, Kuijper EJ,
Committee Centre for Infectious Diseases. … Definitions of Disease Severity by Guideline
Organization Definitions
Infectious Diseases Society of … Australasian Society of Infectious
Diseases 20164
CDI: A + (B or C)
A.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_executive.pdf
April 01, 2012 - The condition is associated with the skin
disease psoriasis, but not all people with
psoriasis will … Additionally,
PsA may predate the development of
skin disease, leading to some diagnostic
uncertainty … Available
therapies for PsA include corticosteroids,
oral disease-modifying antirheumatic
drugs or … Analytic framework for treatment for psoriatic arthritis
DMARDS = disease-modifying antirheumatic … * American College of Rheumatology measure of disease activity: response scores based on 20, 50, or
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
May 07, 2010 - extensively for treatment
of hypertension, heart failure, myocardial infarction, diabetes, and renal disease … disease or events,
symptomatic coronary artery disease,
end-stage renal disease,
quality of life, … , and cerebrovascular disease-
specific)
o Morbidity (cardiac events [MI], heart failure, cerebral … vascular disease or events
[including stroke], symptomatic coronary artery disease, end-stage renal … disease,
peripheral vascular disease [as clinically manifest, not markers of], quality of life)
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
September 01, 2012 - monitoring.3,6 The SFLC assay may also be the only means of detecting a
disease marker in some disease … o Studies of only patients with disease reflects the extreme end of the spectrum of
disease severity … 1
*Polyclonal gammopathy is seen in a diverse range of inflammatory and neoplastic diseases where clonal … Poor, since PCD is a rare disease. … 1
*Polyclonal gammopathy is seen in a diverse range of inflammatory and neoplastic diseases where clonal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
January 01, 2007 - extensively for treatment of hypertension,
heart failure, myocardial infarction, diabetes, and renal
disease … disease-specific mortality) and morbidity (cardiac events
[myocardial infarction], heart failure, cerebral … vascular disease
or events [including stroke], symptomatic coronary artery
disease, end stage renal … disease, peripheral vascular disease,
and quality of life).
4Safety outcomes considered were overall … (either based on creatinine, GFR, or
renal disease) proteinuria).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
March 01, 2012 - , CHF with or without preserved LV
function, diabetes, peripheral arterial disease, chronic kidney disease … disease, or chronic kidney disease) on ACEI/ARB/DRI effectiveness
or harms in patients with hypertension … disease, prior coronary
revascularization; single- vs. multi-vessel coronary artery disease) on ACE-I … , peripheral vascular disease,
diabetes, chronic kidney disease, or congestive heart failure. … ICD-9 (International
Classification of Diseases, Ninth Revision) and CPT (Current Procedural Terminology
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
January 10, 2012 - duration, baseline disease severity, affected BSA, disease location, number and
type of previous treatments … oral
solution, intra-
lesional)
‡ Approved for use in endocrine and rheumatic disorders; collagen diseases … ; dermatologic
diseases including pemphigus, bullous dermatitis herpetiformis, severe erythema multiforme … mycosis fungoides, severe psoriasis, and
severe seborrheic dermatitis; allergic states; ophthalmic diseases … ; respiratory disease;
hematologic disorders; neoplastic disease; edematous states; gastrointestinal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0334_08-04-2010.pdf
January 01, 2010 - events
(e.g., ischemic stroke, symptomatic peripheral arterial disease), or (3) undergoing
percutaneous … s): (1) Patients with acute coronary syndrome, (2) patients who have
suffered other cardiovascular disease-related … events (e.g., ischemic stroke, symptomatic
peripheral arterial disease), or (3) patients undergoing … Outcome(s): Recurrent ischemic events, stent thromboses, cardiovascular disease-
related morbidity and … While clopidogrel may decrease morbidity and mortality associated with several cardiovascular
diseases
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-databases-methods_research.pdf
May 01, 2008 - Lewy bodies, and mixed forms of dementia. 1 ADRD
are prevalent, devastating, and costly diseases affecting … Alzheimer’s disease was defined using the 331 code. … Rates of use were highest among those with a claim for Alzheimer’s Disease. … Alzheimer disease in the US population:
Prevalence estimates using the 2000 census. … The
accuracy of medicare claims data in identifying
Alzheimer's disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-hospitalizations_research.pdf
October 01, 2008 - selected common (pneumonia and congestive heart failure) and less frequent (sepsis, invasive
pneumococcal diseases … serious renal (patients on hemodialysis), liver (hepatic coma and hepatorenal
syndrome), or respiratory diseases … definitions for community-acquired pneumonia, sepsis, congestive heart
failure, invasive pneumococcal diseases … Assessing the ability of our definitions to identify rare conditions, such as invasive
pneumococcal diseases … This PPV depends on disease prevalence and the specificity of the
definitions7, and when disease prevalence
-
effectivehealthcare.ahrq.gov/products/copd-management/research